Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Max Bayer
Pharma Reporter
mbayer@endpointsnews.com
author articles
Novartis’ Kisqali snags FDA approval to reduce recurrence in patients with early forms of breast cancer
9 months ago
Pharma
FDA+
Bad trip: How culture conflict and a need for cash nearly broke Lykos
9 months ago
People
In Focus
European regulators fortify single-arm trial advice, but underscore preference for placebo-controlled designs
9 months ago
FDA+
Arbor Biotechnologies cuts early-stage discovery work, lays off staff
10 months ago
People
R&D
Aurinia restructures board, bringing in Kevin Tang and keeping CEO
10 months ago
People
Neurocrine culls Phase 2 neuropsych med after failing to validate earlier data
10 months ago
R&D
J&J expands Tremfya into IBD with new FDA approval
10 months ago
Pharma
FDA+
Roche says its Carmot-acquired obesity pill is effective in early study
10 months ago
R&D
Adicet follows other cell therapy biotechs in autoimmune pivot
10 months ago
R&D
Pharma
Roche's dual GLP-1/GIP results show promising weight loss, but also high rates of vomiting
10 months ago
R&D
Pharma
Federal judge rejects pharma industry’s request to halt Maryland’s 340B law
10 months ago
Pharma
Law
Cigna offers discounted Stelara biosimilar, building on Humira move
10 months ago
Pharma
Updated: Lykos CEO Amy Emerson resigns
10 months ago
People
Moderna’s mpox vaccine outperforms approved version in preclinical study
10 months ago
R&D
Pharma
Transplant biotech eGenesis snags $191M after first use of gene-edited pig kidney
10 months ago
Financing
R&D
BioAge files for IPO, riding momentum for weight loss drugs
10 months ago
Financing
R&D
Dana-Farber chief Laurie Glimcher set to leave storied cancer center
10 months ago
People
ProKidney axes one Phase 3 study, aims for 'expedited approval pathway' using another
10 months ago
R&D
Sanofi’s BTK inhibitor goes 1-for-3 in key MS trials, slows disability progression
10 months ago
R&D
Pharma
Biosecure vote slated for September
10 months ago
China
FDA+
FDA’s drug evaluation wing launches new AI oversight panel
10 months ago
FDA+
UK government partners with pharma on new £400M life science infusion
10 months ago
R&D
Pharma
Widening GLP-1 coverage could cost Medicare almost $150B annually, study finds
10 months ago
Pharma
Semaglutide may come with a higher risk of suicidal thoughts, JAMA study finds
10 months ago
Pharma
First page
Previous page
8
9
10
11
12
13
14
Next page
Last page
